PMCPA Case Analysis

Over 2,000 real rulings β€” analysed for what they mean to your team. Published every day.

All Cases PMCPA Case of the Week PMCPA Cases

Showing 1914 cases

2021
CASE
AUTH/3465/2/21 Vifor Pharma

AUTH/3465/2/21: Complainant v Vifor β€” Venofer symposium and alleged off-licence promotion (No breach)

Anonymous UK health professional alleged a Vifor-sponsored PIVOTAL sub-analysis symposium promoted off-licence Venofer use. Panel found PIVOTAL dosing aligned with clinically accepted…

2021
CASE
AUTH/3498/3/21 Leo

LEO Pharma: late and incomplete disclosure of patient organisation support (AUTH/3498/3/21)

Ex-employee alleged errors/omissions in LEO’s patient organisation support list. PMCPA found late disclosure of 2019 payments and an omitted donation; Clause 2…

2020
CASE
AUTH/3411/10/20 AstraZeneca

Daiichi Sankyo & AstraZeneca: UK employees’ LinkedIn β€˜likes’ brought US trial post into UK Code scope (AUTH/3411/10/20, AUTH/3412/10/20)

UK employees β€˜liked’ a US LinkedIn post linking to an Enhertu Phase 3 trial press release. Panel said the β€˜likes’ proactively disseminated…

2020
CASE
AUTH/3436/12/20 Janssen

Janssen: Stelara homecare service ran for 28 months without oversight, triggering Clause 2 and public reprimand (AUTH/3436/12/20)

Janssen admitted it failed to oversee a nurse-led Stelara homecare service that continued after β€œtermination”, with missing contracts, inadequate vendor PV/product training…

2021
CASE
AUTH/3521/6/21 AstraZeneca ⭐ Case of the Week

AstraZeneca: β€œNon-promotional” EAP webinar ruled promotional and disguised promotion (Calquence) (AUTH/3521/6/21)

An invitation-only Calquence EAP β€œnon-promotional” webinar used positive case studies and lacked certified slides. PMCPA ruled it was promotional material and that…

2021
CASE
AUTH/3558/9/21 Sanofi

Sanofi employee complaint about β€œinsight gathering” (KAM calls and virtual EKC event): no breach (AUTH/3558/9/21)

Anonymous employee alleged KAM β€œinsights” sharing raised GDPR and covert marketing insight concerns, plus a training event shifting to insight gathering. Panel…

2021
CASE
AUTH/3525/6/21 Novo Nordisk

Novo Nordisk: LinkedIn-promoted β€œfree” weight management course and funded Saxenda PGDs ruled disguised promotion and inducement (AUTH/3525/6/21)

Novo Nordisk-sponsored obesity training promoted Saxenda via LinkedIn without clear upfront sponsorship, certification or prescribing info. Funding Β£79 Saxenda PGDs for HCPs…

2021
CASE
AUTH/3584/11/21 Roche Products

Roche LinkedIn β€˜Experience’ sections: references to POMs ruled not promotional (No breach) | AUTH/3584/11/21

Health professional alleged Roche employees’ LinkedIn β€˜Experience’ sections promoted POMs without mandatory info. Panel and Appeal Board found the content was CV-style,…

2022
CASE
AUTH/3617/3/22 GlaxoSmithKline

GSK employee’s personal LinkedIn post about β€œshingles prevention” and Shingrix role: no breach (AUTH/3617/3/22)

Complaint alleged Shingrix promotion on an employee’s personal LinkedIn post/profile. Panel found no promotion to the public or HCPs and ruled no…

2019
CASE
AUTH/3236/8/19 Merck Sharp & Dohme

AUTH/3236/8/19: Health professional v Merck Sharp & Dohme – incorrect Disclosure UK transfer of value entry

A health professional challenged an incorrect Disclosure UK entry showing MSD provided financial support. The Panel found the disclosure inaccurate and misleading,…

2019
CASE
Gilead Sciences Europe

Gilead ruled in breach for failing to comply with an undertaking: Biktarvy tolerability claim remained on website

ViiV and the PMCPA Director complained that Gilead continued to display a Biktarvy tolerability claim on a UK-accessible website after giving an…

2019
CASE
Allergan

Allergan: Botox pack shots and award reposts on Instagram found to promote a POM to the public

Allergan reposted Instagram Stories and employee posts that included Botox pack shots and an β€œInjectable Product of the Year” reference. The Panel…

2019
CASE
AUTH/3285/12/19 Daiichi-Sankyo UK

AUTH/3285/12/19: Ex-employee v Daiichi-Sankyo – Underreporting transfers of value on Disclosure UK

An ex-employee alleged Daiichi-Sankyo grossly underreported conference-related transfers of value on Disclosure UK (2016–2018). The Panel found multiple disclosure and record-keeping breaches,…

2019
CASE
Colonis Pharma ⭐ Case of the Week

Colonis voluntary admission: wrong prescribing information in promotional letter for Melatonin Oral Solution

Colonis admitted a promotional letter for Melatonin 1mg/ml Oral Solution included prescribing information for Melatonin 3mg tablets. The Panel ruled breaches including…

2021
CASE
GlaxoSmithKline ⭐ Case of the Week

GSK breach upheld on taskforce website: sponsorship not clearly acknowledged β€œfrom the outset” (Clause 25.3)

GSK funded a patient-organisation-hosted taskforce. PMCPA found sponsorship disclosure wasn’t clear β€œfrom the outset” because it was only accessible via small footer…

Ask questions about any PMCPA case

Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases β€” ask about precedents, clauses, and how they apply to your situation.

⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week β€” free.

Subscribe Free
🎓 AQP Training